228 related articles for article (PubMed ID: 8436624)
1. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E
J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624
[TBL] [Abstract][Full Text] [Related]
2. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
Hietala J; Någren K; Lehikoinen P; Ruotsalainen U; Syvälahti E
J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
[TBL] [Abstract][Full Text] [Related]
3. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.
Antonini A; Leenders KL; Reist H; Thomann R; Beer HF; Locher J
Arch Neurol; 1993 May; 50(5):474-80. PubMed ID: 8489403
[TBL] [Abstract][Full Text] [Related]
4. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
[TBL] [Abstract][Full Text] [Related]
5. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
Hietala J; Syvälahti E; Vuorio K; Någren K; Lehikoinen P; Ruotsalainen U; Räkköläinen V; Lehtinen V; Wegelius U
Arch Gen Psychiatry; 1994 Feb; 51(2):116-23. PubMed ID: 7905257
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
Antonini A; Leenders KL
Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
Rinne JO; Hublin C; Partinen M; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Laihinen A
Neurology; 1995 Sep; 45(9):1735-8. PubMed ID: 7675236
[TBL] [Abstract][Full Text] [Related]
8. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Schlyer DJ; Hitzemann R; Wolf AP
Psychiatry Res; 1996 May; 67(1):11-6. PubMed ID: 8797238
[TBL] [Abstract][Full Text] [Related]
9. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
Farde L; Eriksson L; Blomquist G; Halldin C
J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555
[TBL] [Abstract][Full Text] [Related]
11. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
[TBL] [Abstract][Full Text] [Related]
12. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence.
Hietala J; West C; Syvälahti E; Någren K; Lehikoinen P; Sonninen P; Ruotsalainen U
Psychopharmacology (Berl); 1994 Nov; 116(3):285-90. PubMed ID: 7892418
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride.
Khan N; Antonini A; Parkes D; Dahlitz MJ; Meier-Ewert K; Weindl A; Leenders KL
Neurology; 1994 Nov; 44(11):2102-4. PubMed ID: 7969966
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo.
Pohjalainen T; Rinne JO; Någren K; Syvälahti E; Hietala J
Am J Psychiatry; 1998 Jun; 155(6):768-73. PubMed ID: 9619148
[TBL] [Abstract][Full Text] [Related]
15. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
Ginovart N; Farde L; Halldin C; Swahn CG
Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
[TBL] [Abstract][Full Text] [Related]
16. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.
Volkow ND; Gur RC; Wang GJ; Fowler JS; Moberg PJ; Ding YS; Hitzemann R; Smith G; Logan J
Am J Psychiatry; 1998 Mar; 155(3):344-9. PubMed ID: 9501743
[TBL] [Abstract][Full Text] [Related]
17. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
Farde L; Hall H; Pauli S; Halldin C
Synapse; 1995 Jul; 20(3):200-8. PubMed ID: 7570351
[TBL] [Abstract][Full Text] [Related]
18. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
Ito H; Okubo Y; Halldin C; Farde L
Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552
[TBL] [Abstract][Full Text] [Related]
19. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.
Rinne JO; Laihinen A; Rinne UK; Någren K; Bergman J; Ruotsalainen U
Mov Disord; 1993 Apr; 8(2):134-8. PubMed ID: 8474478
[TBL] [Abstract][Full Text] [Related]
20. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
Ginovart N; Farde L; Halldin C; Swahn CG
Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
